Wozniak Lab
Welcome to the Wozniak? Lab
Bacterial corneal infection (bacterial keratitis) is a major contributor to vision loss throughout the world, resulting in nearly 2 million new cases of blindness annually. Yet, despite the prevalence of this disease and its significant morbidity, there is still much to learn regarding how bacteria successfully initiate, establish and maintain infection. Our lab takes both basic science and translational approaches to study the pathogenesis of bacterial keratitis and to develop novel antimicrobial therapies to treat this blinding disease.
Rachel A. F. Wozniak, M.D., Ph.D.
Principal Investigator
- Efficacy of a Novel Antibiotic Drug Combination Toward Multidrug-Resistant Ocular Pathogens.; Cornea. 2024 Mar 26.
- Reimagining the Past: A Future for Antibiotic Drug Discovery in Ophthalmology.; Cornea. 2023 Sep 12.
- Editorial: Women in antimicrobial resistance and new antimicrobial drugs.; Frontiers in cellular and infection microbiology; Vol 13, pp. 1263568. 2023 Aug 25.
Affiliations
Contact Us
Wozniak? Lab
601 Elmwood Ave
Rochester, NY 14642